PPARA and fatty liver disease: The PPARδ-stimulated hepatic fatty accumulation we observed in our study was accompanied by substantial weight loss, if not preceded, with exceptions of PPARα-KO and PPARδ-KO mice fed GW501516, where neither weight loss nor liver steatosis was observed.